NASDAQ: NRSN - NeuroSense Therapeutics Ltd.

Yield per half year: -3.64%
Dividend yield: 0.00%
Sector: Healthcare

Share chart NeuroSense Therapeutics Ltd.

Extended chart Simple chart
Financial Markets by TradingView

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. Its lead product is PrimeC, an extended-release oral formulation of a fixed dose combination of ciprofloxacin and celecoxib for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd.

more details
was incorporated in 2017 and is headquartered in Herzliya, Israel.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-12-09
ISIN IL0011809592
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.neurosense-tx.com
Цена ао 1.09
Change price per day: 0% (1.06)
Change price per week: +11.58% (0.95)
Change price per month: -9.83% (1.1756)
Change price per 3 month: +2.42% (1.035)
Change price per half year: -3.64% (1.1)
Change price per year: -33.75% (1.6)
Change price per 3 year: -62.54% (2.83)
Change price per year to date: -22.06% (1.36)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV -5.5 0
P/E 0 0
EV/EBITDA -0.5877 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % -355.16 0
ROE, % 601.92 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0108 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 717.92 10
Yield EPS, % 560.99 10
Total: 8
More

Institutions Volume Share, %
Armistice Capital, LLC 662000 4.86
Meitav Investment House Ltd. 95000 0.7
HRT Financial LP 13998 0.1
Citadel Advisors Llc 11702 0.09
UBS Group AG 5496 0.04
CWM, LLC 1000 0.01



Head Job title Payment Year of birth
Mr. Alon Ben-Noon Co-Founder, CEO & Director 619k 1979 (46 years)
Mr. Or Eisenberg Chief Financial Officer 378k 1981 (44 years)
Dr. Ferenc Tracik M.D. Chief Medical Officer 513k 1964 (61 year)
Ms. Hagit Binder Chief Operation Officer N/A 1978 (47 years)
Dr. Niva Russek-Blum Ph.D. Chief Technology Officer N/A 1979 (46 years)
Ms. Yael Barak VP of Quality & Compliance N/A 1970 (55 years)
Ms. Keren Pushett Head of HR N/A
Mr. Eidan Loushi C.R.A. N/A

Address: Israel, Herzliya, Building B - open in Google maps, open in Yandex maps
Website: https://www.neurosense-tx.com